Get the Truth about Zantac Lawsuits
The drug ranitidine, best known under the brand name Zantac, has been linked to cancer and people are suffering. At The Law Offices of Larry H. Parker we understand the many ways that this can affect users and their families. We understand that you deserve compensation for the damages you have incurred. Get the facts about Zantac lawsuits and then contact The Law Offices of Larry H. Parker at 800-333-0000 to request a free case evaluation.
Did Zantac Prioritize Profits Over People?
Evidence shows that the makers of Zantac knew that one of the components of it (NDMA) was a cancer-causing chemical. They allegedly concealed this fact to keep selling their product and to continue profiting from a drug they allegedly knew could cause cancer in their customers.
The FDA has Called for the Immediate Removal of Zantac and Other Ranitidine Drugs from the Market
On April 1, 2020 the United States Food and Drug Administration (FDA) called for manufactures of Zantac and other over-the-counter drugs made with ranitidine to pull their products from the market. Why? Because of the alleged risk of linked cancer.
Did Testing in 2019 Show that NDMA Was Present in Zantac and other Ranitidine Drugs?
There is evidence that in 2019, preliminary testing found that there the known carcinogen N-Nitrosodimethylamine (NDMA) was present in Zantac and other ranitidine medications. However, investigations found that time and high temperatures caused the levels of NDMA to increase within the medication, thus rendering it particularly unsafe.
The FDA suggested that users stop taking over-the-counter medications with ranitidine, and those who were taking prescription-strength versions should talk to their medical team about other treatment choices. In October of 2019, Sanofi, the largest generic drug maker in the world, recalled batches of ranitidine. Since then, 22+ countries have banned, recalled, or stopped shipping ranitidine, and four countries have launched their own investigations.
In September 2019, major retailers including CVS and Walgreens removed Zantac and generic brands of ranitidine from their shelves due to the growing evidence of a link between those drugs and cancer. Both companies offered refunds to consumers who had bought Zantac from their stores. Generic drug makers have also recalled their ranitidine products.
Evidence is becoming plentiful that the big pharma companies that make Zantac (Sanofi and Boehringer Ingelheim) concealed the known risks of Zantac from those who used their drugs. They allegedly did this as their company exceeded $1 billion in sales.
The Facts about Zantac
Zantac is used to treat heartburn, ulcers of the stomach, ulcers of the intestines, acid reflux, and other issues and has been on the market since the early 1980s. Upwards of fifteen million people have a prescription to Zantac and there are countless other over-the-counter users of Zantac and other ranitidine medications. Zantac was the first drug to generate more than $1 billion in sales.
Zantac is an H2 blocker, which means that it works by reducing how much acid is produced by the stomach. Dosages vary between 75 and 150mg per tablet, with some patients taking a once-daily 300 mg dosage.
Zantac Has Been Linked to Many Types of Cancer
Zantac has been linked to a number of cancer diagnoses including:
- Non-Hodgkin’s Lymphoma
- Multiple Myeloma
If you were diagnosed with one of the above cancers after using Zantac on a regular basis for at least one year, you might be able to join the more than 100 lawsuits filed nationwide that are designed to finally hold the manufacturers responsible. You can request a free, confidential, and no-risk consultation with The Law Offices of Larry H. Parker at 800-333-0000 to learn more about your options.